ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...